Pfizer Limited (PFIZER) Share Analysis
NSE · Healthcare · Pharmaceuticals
Pfizer Limited (NSE: PFIZER) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 14 Nov 2026, the share price was ₹3,847.00, P/E 115, ROE 19.8%.
Get the AI verdict on PFIZER: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
PFIZER chart with trendlines
Is PFIZER a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Pfizer Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
PFIZER key facts
| Price and valuation | |
|---|---|
| Share price | ₹3,847.00 |
| Market cap | ₹17,601 Cr |
| P/E ratio | 115 |
| P/B ratio | 12.74 |
| EPS | ₹166.49 |
| Book value per share | ₹302.00 |
| Dividend yield | 1.95% |
| 52-week range | |
| 52-week high | ₹5,257.00 |
| 52-week low | ₹3,589.00 |
| Face value | ₹10.00 |
| Shareholding pattern | |
| Promoters | 63.92% |
| FIIs | 1.63% |
| DIIs | 17.52% |
| Public | 16.93% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.